DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2021
    • New Researcher Network
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2020
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
  • About
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • External Events
    • 2021 ISAM Congress
    • RDD 2021
  • Contact
  • The Aerosol Society logo
loading...

Dr Kev Dhaliwal :

Dr Kev Dhaliwal

Senior Clinical Lecturer, MRC Centre for Inflammation Research, University of Edinburgh

Kev Dhaliwal, MBChB (Hons), BSc (Hons), PhD, FRCP is a Senior Clinical Lecturer in Pulmonary Molecular Imaging at the MRC Centre for Inflammation Research in the Queen’s Medical Research Institute (QMRI) and Consultant Physician in Respiratory Medicine. After graduating from Edinburgh Medical School, he completed general professional training in London before returning to Edinburgh to undertake a MRC Clinical Training Fellowship. He combined clinical and academic training as a clinical lecturer and developed a research theme in pulmonary optical molecular imaging. Kev is chief investigator on 5 first-in-man trials ranging from the intensive care unit to lung cancer evaluating optical imaging approaches. He leads the interdisciplinary hub of scientists in the QMRI as part of the Proteus Project (www.proteus.ac.uk), the UK’s largest healthcare bio-photonics project which is an Engineering Physical Sciences Research Council Interdisciplinary Research Collaboration developing next-generation translational technologies for in situ pulmonary molecular imaging and sensing in pulmonary critical care. He is the Medical School lead for the OPTIMA EPSRC and MRC Centre for Doctoral Training in Optical Medical Imaging (www.optima-cdt.ac.uk) which embeds entrepreneurship within the training programme. In 2014, he co-founded Edinburgh Molecular Imaging (EMI) (www.edinimage.com) which is developing optical molecular imaging approaches for colorectal cancer detection and intraoperative surgical guidance. As a clinical founder director for EMI, he is establishing global clinical trials of optical imaging in the US, Europe and Far East and developing networks to expedite clinical adoption.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2021 Drug Delivery to the Lungs Website design: definingdesign.co.uk